WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF RASANJANADI ANJANA AND HARIDRA SEKA IN THE TREATMENT OF THE PRAKLINNVARTMA (BLEPHARITIS)

*Dr. Abhilasha, Dr. Aditi and Dr. Punita

.

Abstract

Praklinnvartma is one of the disease of the Vartma(eyelids). On the basis of the etiology, clinical features and etiopathogenesis it has been correlated with the Anterior Blepharitis. Anterior Blepharitis is the chronic bacterial infection of the anterior part of the eyelid margin. It may undergo the spontaneous resolution but never cure or may progress into further complications which can result into the vision loss as well. This study was carried out to see the effect of Rasanjandi Anjana in the one group having 20 patients. In the other group having 20 patients the Haridra Seka followed by the Rasanjanadi Anjana was given. The overall effect of the therapy was that in both the groups none of the patients has came up with the no relief(unchanged), mild relief(1% – 25%), moderate relief(26% - 50%). In group A patient having the significant relief(51% - 75%) were 61.11% and the patients having the excellent relief(76% - 100%) were 38.89%. The group B only comprises of the patient having the excellent relief(76% - 100%) i.e 100% relief.

Keywords: Praklinnvartma, Rasanjandi Anjana, Vartma(eyelids).


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More